Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Clinical trial NCT01822951 · WITHDRAWN
Trial details
- NCT number
- NCT01822951
- Sponsor
- Ever Neuro Pharma GmbH
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Primary completion
- 2016-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.